Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurocognitive Impairment Assessment in Symptomatic Carotid Occlusion Recanalized Endovascularly

NCT04219774 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT04219774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04219774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurocognitive Impairment Assessment in Symptomatic Carotid Occlusion Recanalized Endovascularly
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2020
Completion date
March 14, 2024
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cognition disorder, occlusion carotid, stroke